For research and educational purposes only. Not medical advice.
NMN Reference
Educational, not medical advice reference for NMN: Nootropic, Longevity, Metabolic; regulatory status, evidence posture, source review, and schedule notes. A…
Reference summary
Small human pilot trials report increased blood NAD+ markers and modest improvements in surrogate longevity markers. Long-term outcome data in healthy adults is absent.
- Categories
- Nootropic, Longevity, Metabolic
- Aliases
- Nicotinamide mononucleotide, β-NMN
- Evidence posture
- human — Regulatory status as a dietary supplement is contested — FDA has indicated NMN is not a lawful dietary ingredient because it is being studied as a drug. Sold as a supplement despite the regulatory uncertainty. Long-term outcome data in healthy adults is absent.
- Regulatory status
- No FDA-approved NMN drug label. NDI status with FDA is contested — FDA has issued letters indicating NMN is not a lawful dietary ingredient because it is being studied as a drug. Sold as a dietary supplement despite the regulatory uncertainty.
- Content review status
- research reference